United Therapeutics (UTHR) Receivables - Net (2009 - 2026)
United Therapeutics' Receivables - Net came in at $310.3 million for Q2 2026, down 18.2% from $379.3 million a year earlier and down 0.5% from the prior quarter.
Powered by 
Analysis
United Therapeutics (UTHR) Receivables - Net (2009 - 2026) Analysis & Trends
At the end of FY2025, United Therapeutics' Receivables - Net was $350.2 million, up 25.4% from FY2024.
- Receivables - Net has increased in each of the last six years, with a five-year compound annual growth rate of 17.3% (FY2020 to FY2025).
- Going back by year, Receivables - Net was $279.3 million in FY2024 (+0.1%), $278.9 million in FY2023 (+26.5%), $220.4 million in FY2022 (+10.9%) and $198.7 million in FY2021 (+26.2%).
- The five-year range for quarterly Receivables - Net is $134.5 million (Q1 2023) to $379.3 million (Q2 2025).
- Year-over-year, Receivables - Net increased in five of the last eight quarters, with growth averaging 7.3%.
- The fastest year-over-year change in Receivables - Net over five years came in Q1 2024 (growth of 128.5%), and the weakest in Q1 2023 (a decline of 21.1%).
- Business Quant data shows UTHR's Receivables - Net at $312 million (Q1 2026), $350.2 million (Q4 2025) and $297.7 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | United Therapeutics | 20.72 Bn | 10.22 Bn | 683.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 310.30 Mn |
| Mar 31, 2026 | 312.00 Mn |
| Dec 31, 2025 | 350.20 Mn |
| Sep 30, 2025 | 297.70 Mn |
| Jun 30, 2025 | 379.30 Mn |
| Mar 31, 2025 | 322.00 Mn |
| Dec 31, 2024 | 279.30 Mn |
| Sep 30, 2024 | 341.80 Mn |
| Jun 30, 2024 | 290.70 Mn |
| Mar 31, 2024 | 307.30 Mn |
| Dec 31, 2023 | 278.90 Mn |
| Sep 30, 2023 | 258.60 Mn |
| Jun 30, 2023 | 272.70 Mn |
| Mar 31, 2023 | 134.50 Mn |
| Dec 31, 2022 | 220.40 Mn |
| Sep 30, 2022 | 231.70 Mn |
| Jun 30, 2022 | 173.40 Mn |
| Mar 31, 2022 | 170.50 Mn |
| Dec 31, 2021 | 198.70 Mn |
| Sep 30, 2021 | 212.80 Mn |
API Access
United Therapeutics Receivables - Net API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-net&ticker=UTHR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-net", "ticker": "UTHR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-net&ticker=UTHR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();